机译:Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Nuffield Department of Primary Care Health Sciences University of Oxford;
Oxford Respiratory Trials Unit Nuffield Department of Medicine University of Oxford;
Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of OxfordInstitute of Immunity and Transplantation University College LondonInfection Inflammation and Immunology UCL Great Ormond Street Institute of Child HealthDepartment of Pharmacology University of LiverpoolCentre for Trials Research Cardiff UniversityLifespan and Population Health Unit University of Nottingham School of MedicineBerry ConsultantsPrimary Care Research Centre University of SouthamptonWindrush Medical PracticeFaculty of Health and Life Sciences University of ExeterGeneral Practice and Primary Care School of Health and Wellbeing College of Medical Veterinary &School of Medicine Dentistry and Biomedical Sciences Queen's University BelfastDivision of Population Medicine Cardiff UniversityDepartment of Microbiology Oxford University Hospitals NHS Foundation Trustand Regional Infectious Diseases Unit North Manchester General Hospital;